DK261490D0 - New pharmaceutical compound - Google Patents

New pharmaceutical compound

Info

Publication number
DK261490D0
DK261490D0 DK261490A DK261490A DK261490D0 DK 261490 D0 DK261490 D0 DK 261490D0 DK 261490 A DK261490 A DK 261490A DK 261490 A DK261490 A DK 261490A DK 261490 D0 DK261490 D0 DK 261490D0
Authority
DK
Denmark
Prior art keywords
pharmaceutical compound
new pharmaceutical
epi
patients
useful
Prior art date
Application number
DK261490A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK261490A priority Critical patent/DK261490D0/da
Publication of DK261490D0 publication Critical patent/DK261490D0/da
Priority to AU88711/91A priority patent/AU657926B2/en
Priority to JP3518142A priority patent/JPH06502171A/ja
Priority to UA93004415A priority patent/UA35567C2/uk
Priority to SK428-93A priority patent/SK282516B6/sk
Priority to PCT/DK1991/000317 priority patent/WO1992007584A1/en
Priority to HU9301253A priority patent/HUT64236A/hu
Priority to CA002095356A priority patent/CA2095356A1/en
Priority to EP91919614A priority patent/EP0558529B1/en
Priority to DE69116380T priority patent/DE69116380T2/de
Priority to CZ93786A priority patent/CZ282497B6/cs
Priority to RU93032613A priority patent/RU2127600C1/ru
Priority to ES91919614T priority patent/ES2083597T3/es
Priority to DK91919614.7T priority patent/DK0558529T3/da
Priority to AT91919614T priority patent/ATE132757T1/de
Priority to GR960400902T priority patent/GR3019514T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
DK261490A 1990-10-31 1990-10-31 New pharmaceutical compound DK261490D0 (da)

Priority Applications (16)

Application Number Priority Date Filing Date Title
DK261490A DK261490D0 (da) 1990-10-31 1990-10-31 New pharmaceutical compound
AT91919614T ATE132757T1 (de) 1990-10-31 1991-10-18 Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
HU9301253A HUT64236A (en) 1990-10-31 1991-10-18 Process for the production of medical preparatives applicable for the treatment of enlarged time of coagulation
EP91919614A EP0558529B1 (en) 1990-10-31 1991-10-18 Pharmaceutical preparation for the treatment of prolonged coagulation time
UA93004415A UA35567C2 (uk) 1990-10-31 1991-10-18 Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
SK428-93A SK282516B6 (sk) 1990-10-31 1991-10-18 Farmaceutický prípravok na liečenie pacientov s predĺženým časom zrážania krvi
PCT/DK1991/000317 WO1992007584A1 (en) 1990-10-31 1991-10-18 Pharmaceutical preparation for the treatment of prolonged coagulation time
AU88711/91A AU657926B2 (en) 1990-10-31 1991-10-18 Pharmaceutical preparation for the treatment of prolonged coagulation time
CA002095356A CA2095356A1 (en) 1990-10-31 1991-10-18 Pharmaceutical preparation for the treatment of prolonged coagulation time
JP3518142A JPH06502171A (ja) 1990-10-31 1991-10-18 長期凝血時間の処置のための薬品製剤
DE69116380T DE69116380T2 (de) 1990-10-31 1991-10-18 Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
CZ93786A CZ282497B6 (cs) 1990-10-31 1991-10-18 Farmaceutický přípravek k léčbě prodloužené doby koagulace
RU93032613A RU2127600C1 (ru) 1990-10-31 1991-10-18 Фармацевтический препарат, обладающий свойством ускорять процесс коагуляции крови, способ ускорения коагуляции крови in vitro и применение ингибитора epi активности в качестве вещества, обладающего свойством ускорять процесс коагуляции крови
ES91919614T ES2083597T3 (es) 1990-10-31 1991-10-18 Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado.
DK91919614.7T DK0558529T3 (da) 1990-10-31 1991-10-18 Farmaceutisk præparat til behandling af forlænget koagulationstid
GR960400902T GR3019514T3 (en) 1990-10-31 1996-04-02 Pharmaceutical preparation for the treatment of prolonged coagulation time

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK261490A DK261490D0 (da) 1990-10-31 1990-10-31 New pharmaceutical compound

Publications (1)

Publication Number Publication Date
DK261490D0 true DK261490D0 (da) 1990-10-31

Family

ID=8113744

Family Applications (2)

Application Number Title Priority Date Filing Date
DK261490A DK261490D0 (da) 1990-10-31 1990-10-31 New pharmaceutical compound
DK91919614.7T DK0558529T3 (da) 1990-10-31 1991-10-18 Farmaceutisk præparat til behandling af forlænget koagulationstid

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK91919614.7T DK0558529T3 (da) 1990-10-31 1991-10-18 Farmaceutisk præparat til behandling af forlænget koagulationstid

Country Status (15)

Country Link
EP (1) EP0558529B1 (da)
JP (1) JPH06502171A (da)
AT (1) ATE132757T1 (da)
AU (1) AU657926B2 (da)
CA (1) CA2095356A1 (da)
CZ (1) CZ282497B6 (da)
DE (1) DE69116380T2 (da)
DK (2) DK261490D0 (da)
ES (1) ES2083597T3 (da)
GR (1) GR3019514T3 (da)
HU (1) HUT64236A (da)
RU (1) RU2127600C1 (da)
SK (1) SK282516B6 (da)
UA (1) UA35567C2 (da)
WO (1) WO1992007584A1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063764A (en) * 1992-06-01 2000-05-16 Washington University & Chiron Corp. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US20030171292A1 (en) 1992-06-01 2003-09-11 Creasey Abla A. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
AU636080B1 (en) * 1992-07-21 1993-04-08 Profy International Corporation Unitary loose sheet binder
US7015194B2 (en) 2000-05-10 2006-03-21 Novo Nordisk A/S Pharmaceutical composition comprising factor VIIa and anti-TFPI
EP1282439B1 (en) * 2000-05-10 2005-11-30 Novo Nordisk Health Care AG PHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIa AND A TFPI INHIBITOR
PL372138A1 (en) 2001-10-15 2005-07-11 Chiron Corporation Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi)
WO2007014749A2 (en) * 2005-07-29 2007-02-08 Universiteit Van Maastricht Regulation of tissue factor activity by protein s and tissue factor pathway inhibitor
KR20110039218A (ko) 2008-06-30 2011-04-15 노보 노르디스크 에이/에스 항－인간 인터루킨－２０ 항체
UA112050C2 (uk) * 2008-08-04 2016-07-25 БАЄР ХЕЛСКЕР ЛЛСі Терапевтична композиція, що містить моноклональне антитіло проти інгібітора шляху тканинного фактора (tfpi)
KR101977846B1 (ko) * 2008-12-19 2019-05-14 박스알타 인코퍼레이티드 Tfpi 억제제 및 사용 방법
CN102325795B (zh) * 2008-12-22 2015-03-25 诺沃—诺迪斯克有限公司 针对组织因子途径抑制剂的抗体
US8454956B2 (en) 2009-08-31 2013-06-04 National Cheng Kung University Methods for treating rheumatoid arthritis and osteoporosis with anti-IL-20 antibodies
EP3708190A1 (en) 2010-02-26 2020-09-16 Novo Nordisk A/S Stable antibody containing compositions
NZ602115A (en) 2010-03-01 2014-12-24 Bayer Healthcare Llc Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
JP5730983B2 (ja) 2010-03-19 2015-06-10 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ Ｔｆｐｉ阻害剤および使用方法
US20130136733A1 (en) 2010-05-28 2013-05-30 Novo Nordisk A/S Stable Multi-Dose Compositions Comprising an Antibody and a Preservative
US9228022B2 (en) 2010-06-30 2016-01-05 Novo Nordisk A/S Antibodies that are capable of specifically binding tissue factor pathway inhibitor
TW201212938A (en) 2010-06-30 2012-04-01 Novo Nordisk As Antibodies that are capable of specifically binding tissue factor pathway inhibitor
NZ629130A (en) 2012-03-21 2016-10-28 Baxalta Inc Tfpi inhibitors and methods of use
WO2014015133A1 (en) 2012-07-19 2014-01-23 National Cheng Kung University Treatment of osteoarthritis using il-20 antagonists
US8603470B1 (en) 2012-08-07 2013-12-10 National Cheng Kung University Use of IL-20 antagonists for treating liver diseases
US8852588B2 (en) 2012-08-07 2014-10-07 National Cheng Kung University Treating allergic airway disorders using anti-IL-20 receptor antibodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87172A (en) * 1987-07-23 1994-12-29 Univ Washington A method of inhibiting the isolation of a purer tissue factor
IL87171A (en) * 1987-11-23 1995-08-31 Monsanto Co ANDC of human tissue factor inhibitor
AU617795B2 (en) 1988-03-17 1991-12-05 Leukotech A/S Heparin-binding proteins, dna coding for them, processes for producing them as well as therapeutic preparations containing them
DK148890D0 (da) * 1990-06-19 1990-06-19 Novo Nordisk As Farmaceutisk praeparat

Also Published As

Publication number Publication date
DE69116380D1 (de) 1996-02-22
HUT64236A (en) 1993-12-28
UA35567C2 (uk) 2001-04-16
RU2127600C1 (ru) 1999-03-20
SK282516B6 (sk) 2002-10-08
SK42893A3 (en) 1993-09-09
EP0558529B1 (en) 1996-01-10
CZ282497B6 (cs) 1997-07-16
ES2083597T3 (es) 1996-04-16
DK0558529T3 (da) 1996-06-03
CZ78693A3 (en) 1993-12-15
EP0558529A1 (en) 1993-09-08
HU9301253D0 (en) 1993-07-28
WO1992007584A1 (en) 1992-05-14
GR3019514T3 (en) 1996-07-31
AU657926B2 (en) 1995-03-30
ATE132757T1 (de) 1996-01-15
DE69116380T2 (de) 1996-07-11
AU8871191A (en) 1992-05-26
CA2095356A1 (en) 1992-05-01
JPH06502171A (ja) 1994-03-10

Similar Documents

Publication Publication Date Title
DK261490D0 (da) New pharmaceutical compound
EE02971B1 (et) Droloksüfeeni või selle soolade kasutamine luuhaiguste vastase ravimi valmistamiseks
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
EA200101156A1 (ru) ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
FI946004A (fi) Lääketieteellisessä toimenpiteessä käytettävä trombiiniverifraktio
ES2044840T3 (es) Composiciones estabilizadas del activador del plasminogeno de tejido humano.
DE69130586T2 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
DE68903092T2 (de) Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.
ES2058343T3 (es) Piridinas disubstituidas.
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
ATE87476T1 (de) Fluessige orale formulierung.
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
DE68905076T2 (de) Pharmazeutische Zusammensetzung für die Behandlung von Hautwunden.
DE69300037T2 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
DK0669826T3 (da) (-)-Metrifonatholdigt lægemiddel
ATE128358T1 (de) Therapeutische mittel für diabetisches gangrän.
DK102988D0 (da) Middel med antidepressiv virkning
ATE222103T1 (de) Inklusionskomplexe in waessriger loesung
SE8802040D0 (sv) New use
SE9602262D0 (sv) New use of derivatives of cystine
DE3772047D1 (de) Pyrazin zur behandlung von haemodynamischen und metabolischen krankheiten.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment